| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | R$ 1.70B | R$ 1.75B | R$ 1.37B | R$ 1.41B | R$ 1.37B |
| Gross Profit | R$ 652.52M | R$ 658.75M | R$ 490.25M | R$ 667.88M | R$ 665.93M |
| Operating Income | R$ 329.75M | R$ 341.80M | R$ 211.54M | R$ 449.93M | R$ 456.87M |
| EBITDA | R$ 394.08M | R$ 406.15M | R$ 405.23M | R$ 523.28M | R$ 530.17M |
| Net Income | R$ 294.95M | R$ 217.21M | R$ 249.81M | R$ 363.37M | R$ 325.22M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | R$ 615.09M | R$ 492.87M | R$ 407.31M | R$ 643.65M | R$ 922.82M |
| Total Assets | R$ 3.64B | R$ 3.41B | R$ 3.05B | R$ 2.50B | R$ 2.33B |
| Total Debt | R$ 599.13M | R$ 558.95M | R$ 608.54M | R$ 311.71M | R$ 374.52M |
| Net Debt | R$ 553.53M | R$ 525.63M | R$ 577.04M | R$ 297.60M | R$ 322.65M |
| Total Liabilities | R$ 1.38B | R$ 1.26B | R$ 1.06B | R$ 681.11M | R$ 693.16M |
| Stockholders' Equity | R$ 2.27B | R$ 2.16B | R$ 2.00B | R$ 1.82B | R$ 1.64B |
| Cash Flow | |||||
| Free Cash Flow | R$ -39.80M | R$ 366.06M | R$ 105.59M | R$ -8.23M | R$ -23.64M |
| Operating Cash Flow | R$ 222.24M | R$ 507.20M | R$ 220.56M | R$ 171.90M | R$ 153.98M |
| Investing Cash Flow | R$ -154.72M | R$ -314.71M | R$ -356.81M | R$ 132.96M | R$ -870.32M |
| Financing Cash Flow | R$ -51.70M | R$ -190.67M | R$ 186.09M | R$ -342.62M | R$ 698.01M |
Blau Farmaceutica SA (BR:BLAU3)
:BLAU3
